73.62 USD
+0.28 (+0.38%)
73.62 USD
0 (0%)
HSIC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. HSIC has a medium profitability rating, but doesn't score so well on its financial health evaluation. HSIC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year HSIC was profitable.
In the past year HSIC had a positive cash flow from operations.
In the past 5 years HSIC has always been profitable.
Each year in the past 5 years HSIC had a positive operating cash flow.
1.2 Ratios
The Return On Assets of HSIC (3.52%) is better than 66.00% of its industry peers.
With a decent Return On Equity value of 11.63%, HSIC is doing good in the industry, outperforming 76.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.64%, HSIC is in the better half of the industry, outperforming 66.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HSIC is in line with the industry average of 9.42%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| ROIC | 6.64% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
1.3 Margins
With a decent Profit Margin value of 3.02%, HSIC is doing good in the industry, outperforming 66.00% of the companies in the same industry.
In the last couple of years the Profit Margin of HSIC has declined.
HSIC's Operating Margin of 5.94% is fine compared to the rest of the industry. HSIC outperforms 63.00% of its industry peers.
HSIC's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 31.19%, HSIC perfoms like the industry average, outperforming 59.00% of the companies in the same industry.
In the last couple of years the Gross Margin of HSIC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.94% | ||
| PM (TTM) | 3.02% | ||
| GM | 31.19% |
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
2. Health
2.1 Basic Checks
HSIC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HSIC has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HSIC has less shares outstanding
HSIC has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.63 indicates that HSIC is not a great score, but indicates only limited risk for bankruptcy at the moment.
HSIC has a Altman-Z score (2.63) which is in line with its industry peers.
HSIC has a debt to FCF ratio of 8.70. This is a slightly negative value and a sign of low solvency as HSIC would need 8.70 years to pay back of all of its debts.
HSIC has a Debt to FCF ratio of 8.70. This is comparable to the rest of the industry: HSIC outperforms 51.00% of its industry peers.
HSIC has a Debt/Equity ratio of 0.91. This is a neutral value indicating HSIC is somewhat dependend on debt financing.
HSIC has a Debt to Equity ratio (0.91) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 8.7 | ||
| Altman-Z | 2.63 |
ROIC/WACC0.79
WACC8.44%
2.3 Liquidity
A Current Ratio of 1.40 indicates that HSIC should not have too much problems paying its short term obligations.
With a Current ratio value of 1.40, HSIC perfoms like the industry average, outperforming 51.00% of the companies in the same industry.
A Quick Ratio of 0.79 indicates that HSIC may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.79, HSIC is doing worse than 76.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
HSIC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.49%, which is quite good.
The Earnings Per Share has been growing slightly by 6.19% on average over the past years.
The Revenue has been growing slightly by 3.51% in the past year.
Measured over the past years, HSIC shows a small growth in Revenue. The Revenue has been growing by 4.88% on average per year.
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
3.2 Future
Based on estimates for the next years, HSIC will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.14% on average per year.
HSIC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.28% yearly.
EPS Next Y5.82%
EPS Next 2Y6.69%
EPS Next 3Y7.97%
EPS Next 5Y8.14%
Revenue Next Year2.47%
Revenue Next 2Y2.91%
Revenue Next 3Y3.2%
Revenue Next 5Y3.28%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.27, which indicates a correct valuation of HSIC.
81.00% of the companies in the same industry are more expensive than HSIC, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.49. HSIC is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 13.65, HSIC is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HSIC indicates a somewhat cheap valuation: HSIC is cheaper than 80.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.69. HSIC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.27 | ||
| Fwd PE | 13.65 |
4.2 Price Multiples
HSIC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HSIC is cheaper than 72.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HSIC is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.34 | ||
| EV/EBITDA | 9.98 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HSIC does not grow enough to justify the current Price/Earnings ratio.
HSIC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.62
PEG (5Y)2.47
EPS Next 2Y6.69%
EPS Next 3Y7.97%
5. Dividend
5.1 Amount
HSIC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
73.62
+0.28 (+0.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners97.3%
Inst Owner Change-5%
Ins Owners0.79%
Ins Owner Change-0.09%
Market Cap8.67B
Revenue(TTM)12.94B
Net Income(TTM)391.00M
Analysts71.82
Price Target78.7 (6.9%)
Short Float %7.05%
Short Ratio4.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.88%
Min EPS beat(2)-9.54%
Max EPS beat(2)5.78%
EPS beat(4)2
Avg EPS beat(4)-1.38%
Min EPS beat(4)-9.54%
Max EPS beat(4)5.78%
EPS beat(8)4
Avg EPS beat(8)-0.56%
EPS beat(12)5
Avg EPS beat(12)-0.94%
EPS beat(16)7
Avg EPS beat(16)0.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.76%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-2.59%
Min Revenue beat(4)-5.06%
Max Revenue beat(4)-0.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)0
Avg Revenue beat(12)-3.01%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)5.1%
PT rev (3m)5.04%
EPS NQ rev (1m)0.27%
EPS NQ rev (3m)-0.35%
EPS NY rev (1m)1.98%
EPS NY rev (3m)1.92%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.68%
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)0.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.27 | ||
| Fwd PE | 13.65 | ||
| P/S | 0.67 | ||
| P/FCF | 24.34 | ||
| P/OCF | 16.2 | ||
| P/B | 2.58 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.98 |
EPS(TTM)4.82
EY6.55%
EPS(NY)5.4
Fwd EY7.33%
FCF(TTM)3.02
FCFY4.11%
OCF(TTM)4.54
OCFY6.17%
SpS109.9
BVpS28.55
TBVpS-15.56
PEG (NY)2.62
PEG (5Y)2.47
Graham Number55.64
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| ROCE | 9.68% | ||
| ROIC | 6.64% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 16.65% | ||
| OM | 5.94% | ||
| PM (TTM) | 3.02% | ||
| GM | 31.19% | ||
| FCFM | 2.75% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
ROICexc(3y)8.17%
ROICexc(5y)8.74%
ROICexgc(3y)19.66%
ROICexgc(5y)20.9%
ROCE(3y)10.93%
ROCE(5y)11.41%
ROICexgc growth 3Y-9.94%
ROICexgc growth 5Y-7.93%
ROICexc growth 3Y-12.98%
ROICexc growth 5Y-8.63%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
F-Score5
Asset Turnover1.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 8.7 | ||
| Debt/EBITDA | 2.85 | ||
| Cap/Depr | 58.69% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 5.16 | ||
| Cash Conversion | 49.81% | ||
| Profit Quality | 91.05% | ||
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.63 |
F-Score5
WACC8.44%
ROIC/WACC0.79
Cap/Depr(3y)61.22%
Cap/Depr(5y)49.53%
Cap/Sales(3y)1.25%
Cap/Sales(5y)0.97%
Profit Quality(3y)112.93%
Profit Quality(5y)114.98%
High Growth Momentum
Growth
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
EPS Next Y5.82%
EPS Next 2Y6.69%
EPS Next 3Y7.97%
EPS Next 5Y8.14%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
Revenue Next Year2.47%
Revenue Next 2Y2.91%
Revenue Next 3Y3.2%
Revenue Next 5Y3.28%
EBIT growth 1Y26.48%
EBIT growth 3Y-5.01%
EBIT growth 5Y0.11%
EBIT Next Year15.69%
EBIT Next 3Y8.36%
EBIT Next 5Y7.01%
FCF growth 1Y-45.15%
FCF growth 3Y1.58%
FCF growth 5Y1.99%
OCF growth 1Y-31.93%
OCF growth 3Y6.12%
OCF growth 5Y4.66%
HENRY SCHEIN INC / HSIC FAQ
Can you provide the ChartMill fundamental rating for HENRY SCHEIN INC?
ChartMill assigns a fundamental rating of 4 / 10 to HSIC.
Can you provide the valuation status for HENRY SCHEIN INC?
ChartMill assigns a valuation rating of 5 / 10 to HENRY SCHEIN INC (HSIC). This can be considered as Fairly Valued.
Can you provide the profitability details for HENRY SCHEIN INC?
HENRY SCHEIN INC (HSIC) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HENRY SCHEIN INC?
The Earnings per Share (EPS) of HENRY SCHEIN INC (HSIC) is expected to grow by 5.82% in the next year.